Abstracts tagged "Rheumatologic Conditions"

Abstract Number: 2301 • 2018 ACR/ARHP Annual Meeting
Trend of Osteoporosis and Osteoporotic Fragility Fractures Among Select Autoimmune Rheumatologic Diseases: Results from National Inpatient Sample
Rashmi Dhital¹, Theresa Lynn², Pragya Shrestha³, Sijan Basnet⁴, Prakash Paudel⁵, Priyadarshani Sharma², Paras Karmacharya⁶ and Dilli Poudel⁷, ¹Reading Hospital-Tower Health System, West Reading, PA, ²Reading Hospital, West Reading, PA, ³Internal medicine, Reading Hospital-Tower Health System, West Reading, PA, ⁴Internal Medicine, Reading Hospital, West Reading, PA, ⁵Internal Medicine, Berkshire Medical Center, Pittsfield, MA, ⁶Division of Rheumatology, Mayo Clinic, Rochester, MN, ⁷Internal Medicine, Reading Hospital-Tower Health System, WEST READING, PA
Background/Purpose: Rheumatologic diseases (RDs) have been associated with an increased risk of osteoporosis (OP) and osteoporotic fractures, however, most patients do not receive diagnosis and…
Abstract Number: 141 • 2015 ACR/ARHP Annual Meeting
Improved Follow-up of Hypertension in Rheumatology Patients: Results of a Pilot
Christie M. Bartels¹, Edmond Ramly², Heather Johnson³, Yingqi Zhao¹, Zhanhai Li⁴, Patrick McBride³, Kristin Steffen Lewicki¹ and Diane Lauver⁵, ¹Department of Medicine, University of Wisconsin (UW) School of Medicine and Public Health (SMPH), Madison, WI, ²Industrial and Systems Engineering, University of Wisconsin-Madison College of Engineering, Madison, WI, ³Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴University of Wisconsin (UW) School of Medicine and Public Health (SMPH), Madison, WI, ⁵University of Wisconsin-Madison School of Nursing, Madison, WI
Background/Purpose: Hypertension is the most common and most modifiable cardiovascular disease (CVD) risk factor, yet it is uncontrolled in ½ of US adults. Hypertension management…
Abstract Number: 673 • 2015 ACR/ARHP Annual Meeting
Characterization of Psoriatic Arthritis [Psa] in a Large, Integrated Health Plan: Demographics, Referral Patterns and Care Management
Vibeke Strand¹, Melody Chin², Arijit Ganguli³, Ridhima Nerlekar⁴, Victoria Kelly⁵, Daniel Chin⁶ and Alice Pressman⁴, ¹Biopharmaceutical Consultant, Portola Valley, CA, ²University of California, San Francisco, San Francisco, CA, ³AbbVie Inc., North Chicago, IL, ⁴Research, Development, and Dissemination, Sutter Health, Walnut Creek, CA, ⁵Rheumatology, Palo Alto Medical Foundation, Palo Alto, CA, ⁶Clinical Evidence and Outcomes, AbbVie, North Chicago, IL
Background/Purpose: Despite guidelines and evidence indicating that early diagnosis and treatment of PsA is critical, few studies have described referral and care-management patterns in a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].